Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multispectral Optoacoustic Imaging (MSOT) as Non-invasive Biomarker for Diagnosis and Monitoring of Neuromuscular Diseases (MSOT-NMD)

NCT06438965 is registered in ClinicalTrials.gov with Children's Hospital of Eastern Ontario as lead sponsor.

NCT NCT06438965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06438965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multispectral Optoacoustic Imaging (MSOT) as Non-invasive Biomarker for Diagnosis and Monitoring of Neuromuscular Diseases (MSOT-NMD)
Lead sponsor
Children's Hospital of Eastern Ontario
Phase
Observational
Overall status
Recruiting
Start date
February 7, 2025
Completion date
July 31, 2028
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuromuscular diseases